Alzheimer’s Association International Conference | July 28 – Aug. 1, 2024 | Philadelphia, USA, and Online
AAIC 2023 at a Glance
2023 Press Releases
- Alzheimer’s Association Statement on Donanemab Phase 3 Data Reported at AAIC 2023
- Researchers Reveal First-Ever U.S. County-Level Alzheimer’s Prevalence Estimates | en español
2023 News Highlights
Plenary Sessions
Rik Ossenkoppele, Ph.D., presents his plenary session, "Tau PET: Towards Implementation in Trials and Clinical Practice."
Cristian Lasagna-Reeves, Ph.D., winner of the Inge-Grundke-Iqbal Award for Alzheimer’s Research, presents his plenary session, "Bassoon Contributes to Tau-seed Propagation and Neurotoxicity."
Cynthia Lemere, Ph.D., presents her plenary session, “The Evolving Role of Complement in Alzheimer’s Disease.”
Marsel Mesulam, M.D., presents his plenary session, "The Aphasic Dementia of Alzheimer’s Disease."
Adesola Ogunniyi presents his plenary session, "The Epidemiology of Dementia in Africa."
Katherine Dawson, Jeffrey Cummings, Catherine Mummery, Rachelle Doody, Michael Irizarry and John Sims participate in a panel discussion on amyloid reduction and biomarker modification.
Ana Quiñones, Ph.D., presents her plenary session, "An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities."
Goldie Byrd, Ph.D., presents her plenary session, "Inclusion in Research and Clinical Trials."
